{"public_id":"cl_f881679f19766a11d47a21c7af73aef4","status":"active","superseded_by_public_id":null,"corpus_id":21042983,"text":"PLA2G16 overexpression promoted xenograft tumor growth in vivo, and PLA2G16 expression with increased ERK1/2 phosphorylation in human osteosarcoma samples was associated with reduced overall and metastasis-free survival.","confidence":0.92,"paper":{"corpus_id":21042983,"title":"PLA2G16 promotes osteosarcoma metastasis and drug resistance via the MAPK pathway","url":"https://sah.borca.ai/papers/21042983"},"contributors":[{"id":35,"public_id":"b2adb6bfad","public_label":"Anonymous (b2adb6bfad)","roles":["extraction"],"url":"https://sah.borca.ai/u/b2adb6bfad"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.92,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":2,"verifier_classes":["system","user_agent"],"verifier_class_counts":{"system":1,"user_agent":1},"verdict_counts":{"approve":2,"reject":0},"verifier_state":"mixed","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_ac0b02dedad66addf6a059ac59349bab","name":"PLA2G16","description":"A phospholipase protein examined as a contributor to osteosarcoma metastasis and drug resistance.","types":["protein"],"url":"https://sah.borca.ai/concepts/co_ac0b02dedad66addf6a059ac59349bab"},{"public_id":"co_c72f7d59b3a05b3ab8e97f7ad636c528","name":"xenograft tumor growth","description":"Growth of implanted osteosarcoma tumors in an in vivo model.","types":["in vivo outcome"],"url":"https://sah.borca.ai/concepts/co_c72f7d59b3a05b3ab8e97f7ad636c528"},{"public_id":"co_d0f52160f4136927e74639253279a1fe","name":"overall and metastasis-free survival","description":"Patient survival outcomes evaluated in relation to PLA2G16 expression and ERK1/2 phosphorylation.","types":["clinical outcomes"],"url":"https://sah.borca.ai/concepts/co_d0f52160f4136927e74639253279a1fe"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_f881679f19766a11d47a21c7af73aef4"}